Wind Tunnel Testing Shows 50% Reduction In Snoring-Related Tissue Vibrations
LEXINGTON, KY, May 28, 2015 CrossCoat Medical LLC. (CCM) is pleased to announce wind-tunnel research has shown a consistently large reduction (50%) in the deformation characteristics associated with snoring and obstructive sleep apnea – “floppiness” and large amplitude vibration.
“Our proposed medical device (CCM-D) involves injections of a protein crosslinker to reduce palatal vibrations and airway blockages due to excessive tissue compliance (floppiness). The matrix crosslinking bonds are formed rapidly offering an almost immediate treatment effect”, says Dr. Hedman.
“We created the wind tunnel to test the treatment in a controlled environment. With the wind tunnel, we are able to create the amount of air flow that is similar to the air flow in the upper airway when the individual is sleeping. We use a laser to measure the deflection of the tissue. The treatment effect was dramatic; better than we had hoped”.
According to Dr. Tom Hedman, CSO of CrossCoat Medical and a leading researcher in soft-tissue biomechanics, “The device forming technology being developed by CCM is based on the body’s own natural response to heal instability and degradation of weakened tissue. The device is designed to immediately strengthen and stabilize the tissue upon application. The CCM device (CCM-D) can be administered as a primary treatment or as an adjunct to surgical procedures. Through the addition of numerous, permanent, chemical bonds, the device significantly stabilizes the tissue, increasing stiffness and durability for immediate and long-term treatment of common problems such as snoring and OSA (obstructive sleep apnea)”.
Snoring can affect the quality of sleep, increase risk of stroke, and lead to obstructive sleep apnea syndrome (OSAS) where the airway is physically obstructed for periods of time during sleep. The reported prevalence of snoring in the U.S. population varies widely, ranging from 14-48%, and the incidence of OSAS is estimated to be between 2-24%. Current treatment methods for snoring include over-the-counter medications, oral devices, and patient administered interventions such as weight loss or posture adjustments, and nasal dilators. Treatment options for the more serious condition of OSAS usually starts with the above treatment modalities but can also include continuous positive airway pressure (CPAP) therapy, or surgical options.
CCM is located on the University of Kentucky’s Coldstream Research Campus in the heart of the Kentucky Bluegrass Region. Coldstream provides ILS with a connection to students, researchers, and resources at the University of Kentucky.